Question 1

What does the MaculaGen test analyze?

Accepted Answer

The MaculaGen test analyzes 14 genetic markers across 12 genes associated with AMD, including key markers CFH and ARMS2. It provides personalized risk stratification with 2-, 5-, and 10-year progression time windows.

Question 2

How is the sample collected?

Accepted Answer

A simple cheek (buccal) swab — painless and takes less than a minute. No blood draw is needed.

Question 3

Who should consider this test?

Accepted Answer

Anyone diagnosed with early or intermediate AMD, those with a family history of macular degeneration, or patients currently taking AREDS supplements who want to confirm they're on the right formulation.

Question 4

How long until I receive results?

Accepted Answer

Results are available within 6–8 weeks of the lab receiving your sample. Both patient and clinician reports are delivered via secure portal.

Question 5

Is this test covered by insurance?

Accepted Answer

Coverage varies by plan. We provide documentation to support claims. Contact us at 1-866-964-5182 for current pricing.

Question 6

Can this test diagnose macular degeneration?

Accepted Answer

No. MaculaGen is a risk stratification tool, not a diagnostic test. It provides genetic risk categories to be interpreted by a qualified eye care professional.

Frequently Asked Questions

About the Test

Still Have Questions?